---
input_text: 'Growth hormone therapy in pre-pubertal children with Noonan syndrome:
  first year growth response and comparison with Turner syndrome. We studied the growth-promoting
  effect of treatment with recombinant human growth hormone in 23 pre-pubertal children
  with Noonan syndrome, aged between 5.4 and 14.3 y, and all with a height < 1.4 SD
  for Tanner standards. The growth response and skeletal maturation after 1 y of recombinant
  human growth hormone treatment (0.15 U/kg/day given by daily injection) in the Noonan
  syndrome patients was compared with the auxological changes observed in a group
  of 17 girls with Turner syndrome with a comparable age and height deficit who were
  treated with recombinant human growth hormone in a similar way. During 1 y of treatment,
  the mean +/- SD height velocity increased by 4.0 +/- 1.6 cm/y in the Noonan syndrome
  group and by 3.6 +/- 1.3 cm/y in the Turner syndrome group. Height SDS for chronological
  age in the Noonan syndrome group increased by 0.53 +/- 0.46 (p < 0.001). In the
  Noonan syndrome patients the changes in height velocity were positively related
  to birthweight (r = 0.48, p < 0.05). The changes in height velocity or height SDS
  were not related to the age, height deficit or a delay in bone age maturation at
  start of treatment. In neither the patients with Noonan syndrome nor Turner syndrome
  was an acceleration of bone maturation found. We conclude that treatment with recombinant
  human growth hormone in pre-pubertal NS patients induces an increase in height velocity
  and height SDS comparable to that observed in Turner syndrome girls.'
raw_completion_output: |-
  primary_disease: Noonan syndrome
  medical_actions: treatment with recombinant human growth hormone; daily injection
  symptoms: height < 1.4 SD for Tanner standards; delay in bone age maturation
  chemicals: recombinant human growth hormone
  action_annotation_relationships: treatment with recombinant human growth hormone TREATS height < 1.4 SD for Tanner standards IN Noonan syndrome; daily injection (with recombinant human growth hormone) TREATS delay in bone age maturation IN Noonan syndrome
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  daily injection (with recombinant human growth hormone) TREATS delay in bone age maturation IN Noonan syndrome

  ===

extracted_object:
  primary_disease: MONDO:0018997
  medical_actions:
    - treatment with recombinant human growth hormone
    - daily injection
  symptoms:
    - height < 1.4 SD for Tanner standards
    - delay in bone age maturation
  chemicals:
    - recombinant human growth hormone
  action_annotation_relationships:
    - subject: treatment
      predicate: TREATS
      object: height < 1.4 SD for Tanner standards
      qualifier: MONDO:0018997
      subject_extension: recombinant human growth hormone
    - subject: daily injection
      predicate: TREATS
      object: delay in bone age maturation
      qualifier: MONDO:0018997
      subject_qualifier: with recombinant human growth hormone
      subject_extension: recombinant human growth hormone
named_entities:
  - id: CHEBI:33281
    label: antibiotics
  - id: MONDO:0006936
    label: pulmonary valve stenosis
  - id: MAXO:0009072
    label: surgical repair
  - id: HP:0001642
    label: pulmonary valve stenosis
  - id: MONDO:0018997
    label: Noonan syndrome
  - id: HP:0004322
    label: short stature
  - id: CHEBI:37845
    label: GH
  - id: MONDO:0011908
    label: Juvenile myelomonocytic leukemia (JMML)
  - id: MAXO:0000747
    label: hematopoietic stem cell transplantation (HSCT)
  - id: HP:0012209
    label: Juvenile myelomonocytic leukemia (JMML)
  - id: MAXO:0010203
    label: echocardiography
  - id: HP:0001663
    label: ventricular fibrillation
  - id: HP:0001639
    label: hypertrophic cardiomyopathy
  - id: HP:0032092
    label: left ventricular outflow tract obstruction
  - id: HP:0030828
    label: Wheezing
  - id: CHEBI:90960
    label: Tiotropium
  - id: HP:0002099
    label: bronchial asthma
  - id: MONDO:0007037
    label: Achondroplasia
  - id: MAXO:0000014
    label: radiotherapy
  - id: MAXO:0035118
    label: Cardiac catheterization
  - id: HP:0001659
    label: Aortic regurgitation
  - id: HP:0001004
    label: Lymphedema
  - id: CHEBI:17347
    label: Testosterone
  - id: MONDO:0005516
    label: osteochondrodysplasias
  - id: MONDO:0008300
    label: Prader-Willi syndrome
  - id: MONDO:0000050
    label: Growth Hormone Deficiency (GHD)
  - id: HP:0001510
    label: Poor growth
  - id: MONDO:0007414
    label: Gorham disease
  - id: HP:0012531
    label: Pain
  - id: HP:0010310
    label: Chylothorax
  - id: MONDO:0007893
    label: Noonan syndrome with multiple lentigines
  - id: HP:0001670
    label: asymmetric septal hypertrophy
  - id: MONDO:0011035
    label: Neurofibromatosis-Noonan syndrome
  - id: HP:0000001
    label: acute lymphoblastic leukemia (ALL)
  - id: HP:0000818
    label: endocrinopathies
  - id: HP:0000789
    label: infertility
  - id: MONDO:0019499
    label: Turner syndrome
  - id: MONDO:0006769
    label: Gastroparesis
  - id: MAXO:0000079
    label: Genetic counseling
  - id: HP:0003270
    label: Bloating
  - id: CHEBI:31515
    label: Domperidone
  - id: HP:0002018
    label: nausea
  - id: MAXO:0010032
    label: heart transplantation
  - id: HP:0001635
    label: heart failure
  - id: HP:0031318
    label: myofiber disarray
  - id: CHEBI:68478
    label: everolimus
  - id: MAXO:0001298
    label: therapy
  - id: HP:0003006
    label: neuroblastoma
  - id: MAXO:0025001
    label: cardiac surgery
  - id: HP:0001627
    label: congenital heart disease
  - id: HP:0011675
    label: Arrhythmias
  - id: HP:0002093
    label: Respiratory insufficiency
  - id: HP:0002090
    label: Pneumonia
  - id: HP:0001631
    label: atrial septal defect
  - id: HP:0001999
    label: Dysmorphic facial features
  - id: HP:0000729
    label: Secundum atrial septal defect (ASD)
  - id: HP:0030957
    label: Ventricular septal aneurysm
  - id: HP:0002875
    label: Exertional dyspnea
  - id: HP:0000316
    label: Hypertelorism
  - id: HP:0000914
    label: Shield chest
  - id: HP:0002943
    label: Thoracic scoliosis
  - id: MONDO:0005212
    label: Rhabdomyosarcoma
  - id: HP:0001263
    label: developmental delay
  - id: HP:0005152
    label: congenital cardiomyopathy
  - id: HP:0002027
    label: abdominal pain
  - id: HP:0002019
    label: constipation
  - id: HP:0031500
    label: abdominal mass
  - id: MONDO:0054588
    label: Noonan syndrome-like disorder with loose anagen hair-2 (NSLH2)
  - id: HP:0001252
    label: Hypotonia
  - id: HP:0001249
    label: Intellectual disability
  - id: HP:0011097
    label: epileptic spasms
  - id: MONDO:0021060
    label: RASopathies
  - id: HP:0010816
    label: epidermal nevi
  - id: HP:0010815
    label: nevus sebaceous
  - id: MONDO:0007783
    label: King syndrome
  - id: HP:0002047
    label: malignant hyperthermia
  - id: MONDO:0006664
    label: Atrial Septal Defect
  - id: HP:0003010
    label: prolonged bleeding time
  - id: CHEBI:4450
    label: Desmopressin
  - id: CHEBI:15365
    label: aspirin
  - id: MONDO:0007950
    label: mastocytosis
  - id: MONDO:0019565
    label: von Willebrand disease
  - id: HP:6000310
    label: Preterm premature rupture of membranes
  - id: HP:0002089
    label: Pulmonary hypoplasia
  - id: HP:0001256
    label: Mild mental retardation
  - id: HP:0025676
    label: fetal pleural effusions
  - id: MONDO:0006497
    label: Cerebral Palsy
  - id: MONDO:0002192
    label: Vulvar angiokeratoma
  - id: HP:0030692
    label: brain tumors
  - id: CHEBI:119915
    label: Fentanyl
  - id: CHEBI:6931
    label: Midazolam
  - id: CHEBI:44915
    label: Propofol
  - id: CHEBI:6121
    label: Ketamine
  - id: CHEBI:9130
    label: Sevoflurane
  - id: HP:0002593
    label: intestinal lymphangiectasia
  - id: MAXO:0035035
    label: lymphography
  - id: HP:0002243
    label: protein-losing enteropathy
  - id: HP:0001508
    label: failure to thrive
  - id: CHEBI:8499
    label: propranolol
  - id: CHEBI:135083
    label: cibenzoline
  - id: MONDO:0015280
    label: cardiofaciocutaneous syndrome
  - id: HP:0032152
    label: keratosis pilaris (KP)
  - id: HP:0100837
    label: ulerythema ophryogenes (UO)
  - id: HP:0000972
    label: palmoplantar hyperkeratosis (PPHK)
  - id: CHEBI:50172
    label: acitretin
  - id: CHEBI:9168
    label: sirolimus
